Kodiak Sciences Announces Third Quarter 2021 Financial Results and Recent Business Highlights

PALO ALTO, Calif.: PALO ALTO, Calif., Nov. 9, 2021 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, today reported business highlights and financial results for the third quarter ended September 30, 2021. "We are...

Click to view original post